David Golub
Co-founder, Chairman of the Board, CEO.

Mr. Golub served as President and CEO of LigoChem,Inc. from 1997 to 2004. Mr. Golub has overseen transactions in early-stage medical technology, biotechnology, environmental remediation, internet, telecommunications and software companies as consulting manager of Seattle-based American Paradigm Corp. From 1987-1992, he served as Senior Associate at a corporate acquisition partnership with GE Capital.
dgolub@profactproteomics.com

Matthew P. Kuruc
Co-founder, Director, President & COO.

Mr. Kuruc is a serial entrepreneur. He was President and a co-founder of Affinity Technology Inc., from 1990 until 1996, when it was acquired. From 1987 to 1990 he held various marketing and sales positions with Amicon Division of W. R. Grace & Co. (now Millipore), and prior to that, product and sales positions with industrial separations equipment suppliers. Mr. Kuruc earned a B.S. degree in Chemical Engineering from Rutgers University.
mkuruc@profactproteomics.com

Swapan Roy, Ph.D.
Co-founder, Director, Chief Scientific Officer.

Dr. Roy is the principal investigator and visionary behind the ProFACT separations chemistries. He has broad experience in engineering matrices for bioseparations, and bioprocess purification. At Hoffman La Roche from 1969 to 1996, he worked as Senior Research Investigator on PEG protein modification, and separation of proteins used in cancer therapy (e.g., interferons, interleukins and cell growth factors). Dr. Roy's company, Biotech Support Group, LLC is an investor in ProFACT as well as a licensor for its consumables. Dr. Roy received his Ph.D. from Calcutta University.
sroy@profactproteomics.com

Pronoy K. Chatterjee, Ph.D.
Director.

Dr. P. K. Chatterjee is a widely recognized expert in health care hygiene products. Awarded 50 US patents, he is the author of 90 scientific publications and two books on adsorbent materials science. He held management positions at Johnson & Johnson for twenty-seven years. Since 1994, he has consulted for corporations throughout North America and Europe, and with United Nations projects in Asia and Central America. Dr. Chatterjee earned Ph.D. and D.Sc. degrees in Cellulose/Polymer Science from Calcutta University and did postdoctoral research at Princeton University and USDA.

John Krupey:
Founder, Co-founder, Consultant.

Dr. Krupey is the inventor and principal investigator of the polymer adsorbent technologies incorporated into the ProFACT™ platform. From 1967 to 1975 while at McGill University and as consultant to Roche Diagnostics, he and colleagues originated the first in vitro blood test for cancer (CEA). His research efforts also have led to other cancer biomarkers, and novel diagnostic detection chemistries. Dr. Krupey received his Ph.D. in Biochemistry from McGill University.

Kiran Madura, Ph.D.
Scientific Advisory Board.

Dr. Madura is a Professor of Biochemistry and Molecular Biology at Robert Wood Johnson Medical School and the inventor of proprietary technology for Ubiquitin and Proteasome bioassays. His laboratory pursues five research projects under two NIH grants. Dr. Madura is author of 31 peer-reviewed publications and is a member of the Cancer Institute of New Jersey and the Board of Scientific advisors for the Carcinogenesis Foundation. He is a founder a Cell Xplore, Inc, and received his Ph.D. in Biology from the University of Rochester.

Meghen Tierney, Ph.D.
Senior Scientist.

Dr. Tierney leads our applications development for molecular profiling and biomarker discovery. Her doctoral doctoral work focused on polycyclic aromatic hydrocarbon (PAH) biodegradation; establishing a systems biology approach to understanding the bacteria capable of metabolizing these carcinogenic compounds. She received her Ph.D. in Environmental Sciences from Rutgers University.

Hans-Ulrich Thomann,
Consultant.

From 1995 to 2001 at Genome Therapeutics, Dr. Thomann developed high throughput methods for large-scale genome analysis and gene expression. As Principal Scientist, he brought his novel pharmacogenomics business, Drug Rescue™ to the biopharma market. Now a consultant to the company, Dr. Thomann received his Ph.D. in Organic Chemistry and Biochemistry from Bavarian Julius-Maximilian University in Germany.

Carmine Mascoli, Ph.D.
Scientific Advisor.

Dr. Mascoli is a retired senior pharmaceutical executive from Baxter Healthcare with extensive experience in product development and management.